Picture of AngioDynamics logo

ANGO — AngioDynamics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

AngioDynamics Inc expected to post earnings of 2  cents a share - Earnings Preview

* AngioDynamics Inc  ANGO.OQ   ANGO.O  is expected to show a
rise
in quarterly revenue when it reports  results on July 12. 
    * The Latham New York-based  company is expected to report 
a
4.3% increase in revenue to $90.732 million from $87 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AngioDynamics Inc
is for
earnings of 2 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $15.5​, above​ its last closing price of $9.39. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Feb. 28 2023  -0.01       -0.01      -0.03     Missed  -300
 Nov. 30 2023  -0.01       -0.01      0.01      Beat    200
 Aug. 31 2022  -0.02       -0.02      -0.06     Missed  -166.7
                                                        ​
 May. 31 2022  0.01        0.01       0.01      Met     33.3
 ​​Feb.        -0.01       -0.01      0.03      Beat    340
 28 2022                                                
 Nov. 30 2021  0.00        0.01       -0.02     Missed  -481​
 Aug. 31 2021  -0.04       -0.04      -0.02     Beat    55.6
 May. 31 2021  0.00        0.00       0.00      Met     100
 This summary was machine generated July 10 at 12:41 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on AngioDynamics

See all news